Castle Biosciences, Inc. (CSTL)
33.79
-0.71
(-2.06%)
USD |
NASDAQ |
Nov 13, 16:00
33.77
-0.02
(-0.06%)
After-Hours: 19:59
Castle Biosciences EPS Diluted (Quarterly) : -0.1338 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1338 |
| June 30, 2026 | -0.0678 |
| March 31, 2026 | -0.4859 |
| December 31, 2025 | -0.0795 |
| September 30, 2025 | -0.0172 |
| June 30, 2025 | 0.1531 |
| March 31, 2025 | -0.9035 |
| December 31, 2024 | 0.3176 |
| September 30, 2024 | 0.0772 |
| June 30, 2024 | 0.3104 |
| March 31, 2024 | -0.0922 |
| December 31, 2023 | -0.0954 |
| September 30, 2023 | -0.2573 |
| June 30, 2023 | -0.7024 |
| March 31, 2023 | -1.098 |
| December 31, 2022 | -0.781 |
| September 30, 2022 | -0.7695 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.0632 |
| March 31, 2022 | -0.9685 |
| December 31, 2021 | -0.2539 |
| September 30, 2021 | -0.4663 |
| June 30, 2021 | -0.3504 |
| March 31, 2021 | -0.1718 |
| December 31, 2020 | -0.2347 |
| September 30, 2020 | -0.2302 |
| June 30, 2020 | -0.0784 |
| March 31, 2020 | 0.0304 |
| December 31, 2019 | 0.1105 |
| September 30, 2019 | 0.0524 |
| June 30, 2019 | -0.1327 |
| March 31, 2019 | -0.1407 |
| September 30, 2018 | -0.261 |
| June 30, 2018 | -0.239 |
| March 31, 2018 | -0.2696 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| RadNet, Inc. | 0.0524 |
| Lumexa Imaging Holdings, Inc. | 0.0746 |
| Quest Diagnostics, Inc. | 2.768 |
| Labcorp Holdings, Inc. | 3.221 |
| OPKO Health, Inc. | -0.0717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.10M |
| Revenue (Quarterly) | 102.89M |
| Total Expenses (Quarterly) | 106.99M |
| Enterprise Value | 798.68M |
| Gross Profit Margin (Quarterly) | 74.00% |
| Profit Margin (Quarterly) | -3.98% |
| Earnings Yield | -2.27% |
| Normalized Earnings Yield | -1.970 |